Literature DB >> 28904302

The incidence and severity of IgA vasculitis with nephritis over a 10-year period in our hospital.

Keishi Yamane1, Yukihiko Kawasaki1, Ryo Maeda1, Shinichiro Ohara1, Kazuhide Suyama1, Mitsuaki Hosoya1.   

Abstract

BACKGROUND: To evaluate the recent frequency of onset and severity of IgA vasculitis with nephritis (IgAVN) in Fukushima Prefecture, we examined the epidemiology and clinico-pathological manifestations of IgAVN in our hospital over a 10-year period.
METHODS: We enrolled 18 patients with IgAVN treated between 2004 and 2013 in the Department of Pediatrics, Fukushima Medical University School of Medicine. These patients were divided into two groups; Group 1 consisted of 12 patients with IgAVN hospitalized between 2004 and 2008 and Group 2 consisted of 6 patients with IgAVN hospitalized between 2009 and 2013. The epidemiology, clinical features, laboratory data, pathological findings, and outcome were retrospectively compared between the two groups.
RESULTS: The numbers of patients with IgAVN per year in Group 2 were lower than that in Group 1. The frequency of patients with higher than grade IIIb disease in Group 2 (50%) was lower than that in Group 1 (94%); furthermore, the frequency of patients with higher than grade IV disease in Group 2 (0%) was lower than that in Group 1 (50%).
CONCLUSIONS: Our findings suggest that the incidence of onset and severity of IgAVN in patients diagnosed between 2009 and 2013 were lower than those in patients diagnosed between 2004 and 2008.

Entities:  

Keywords:  IgA vasculitis with nephritis; bredinine; children; epidemiology; steroid

Mesh:

Year:  2017        PMID: 28904302      PMCID: PMC5792497          DOI: 10.5387/fms.2017-14

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  22 in total

1.  Pathological improvement of IgA nephropathy and Henoch-Schönlein purpura nephritis with urokinase therapy.

Authors:  T Watanabe; S Takahashi; S Nakajo; M Hamasaki
Journal:  Acta Paediatr Jpn       Date:  1996-12

2.  Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study.

Authors:  Maryam Piram; Carla Maldini; Sandra Biscardi; Nathalie De Suremain; Christine Orzechowski; Emilie Georget; Delphine Regnard; Isabelle Koné-Paut; Alfred Mahr
Journal:  Rheumatology (Oxford)       Date:  2017-08-01       Impact factor: 7.580

3.  Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis.

Authors:  Yukihiko Kawasaki; Junzo Suzuki; Ruriko Nozawa; Shigeo Suzuki; Hitoshi Suzuki
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

4.  [Henoch-Schönlein purpura nephritis (HSPN) in children: comparison of the incidence and severity between two 12-year groups].

Authors:  S Moriya; K Iitaka; H Koshino; K Tomonaga; N Kasai
Journal:  Nihon Jinzo Gakkai Shi       Date:  2000-01

Review 5.  Henoch-Schönlein nephritis. A disease with significant late sequelae.

Authors:  R H White
Journal:  Nephron       Date:  1994       Impact factor: 2.847

Review 6.  The pathogenesis and treatment of pediatric Henoch-Schönlein purpura nephritis.

Authors:  Yukihiko Kawasaki
Journal:  Clin Exp Nephrol       Date:  2011-06-23       Impact factor: 2.801

7.  Retrospective study of plasma exchange in patients with idiopathic rapidly progressive glomerulonephritis and vasculitis.

Authors:  A Gianviti; R S Trompeter; T M Barratt; M F Lythgoe; M J Dillon
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

8.  Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura.

Authors:  R Coppo; G Mazzucco; L Cagnoli; A Lupo; F P Schena
Journal:  Nephrol Dial Transplant       Date:  1997-11       Impact factor: 5.992

9.  Report of the Second Task Force on Blood Pressure Control in Children--1987. Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Authors: 
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

10.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.